terrible technical position...yesterday we had a key outside day...was overbought..whole market was overbought..indu..spx..spy..when the rsi gets back into the 30's it may be the best buy ever.... just my opinion..
Shorts covered 4 million shares in the last week..RSI over 74???? With the dividend return over 10% you have to wonder why people don't buy it for the return. Gap below the market has to get filled and the MACD is too out of control for a stock like this....see you at $14....
Short the stock and buy a call...strangle expensive but beware getting harder to borrow the stock...wait for earnings..I do no think they will be so good...
had a good piece on diabetes and bariatric surgery. Sad part, the guy who runs the place testified for VBLOC at the FDA Adcom meeting and he omitted VBLOC in the article...I know..he must be short right???
Hey moron..did you see the last financing? If they succeed there will be no dilution and they have until mid-2017 to get the act together..
the joke was the quote..i think mulroy is a liar an quite inept...i hope he is out of a job by 2018
He has bribed the board with options. I think they should have fired him two years ago. The legacy products are worthless and that is what the market and the pharma companies are saying. Our price is only 398 and that is a show me issue. Focus on what works Bob you dope.
That moron has an agenda..Would not be surprised if he was sent in by Phillip Morris as we can put them in the hurt locker..Undercapitalzed as we are is a problem and 90%of our stock is owned by individuals who will not sell. Shorts are paying 15% to borrow our stock...Ignore the static and wait for Henry to give us some news. He did not present in California today..that should tell you something.
No you are exactly correct..nanoparticle delivery is the best asset we have and that is why some of the legacy assets have to be shelved. Success with 398 if carried forward and accelerated is the best avenue for MACK.
I only wish Mulroy et all had the smarts to see that. Immunology will eventually work. Remember how long it took for mono-clonal antibodies to succeed. We have huge success with our nanoparticles.
Great find...GSK is the leader in the space but with no intellectual property...Gladney is talking to them and others
Porter was buying at $11....wait a few weeks..Mulroy will sell...Insider buying...worst indicator ever...and European approval is built it to the price and the royalties while redacted will not be that great for the first year..Still think the game will be played after the Shire Baxalta deal plays out..But please pay attention to the overall market which will have ore affect on MACK than anything else for the next month or so...We see the market dropping MACK will get hit...that is what took it down to the low $5's....